Stay updated with breaking news from Patrickd Yeramian. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SVB Leerink downgraded shares of Amylyx Pharmaceuticals (NASDAQ:AMLX – Free Report) from an outperform rating to a market perform rating in a research report released on Monday morning, Marketbeat reports. Several other equities research analysts have also recently commented on the company. Robert W. Baird cut Amylyx Pharmaceuticals from an outperform rating to a neutral […]
The Goldman Sachs Group restated their neutral rating on shares of Amylyx Pharmaceuticals (NASDAQ:AMLX – Free Report) in a report released on Friday morning, Marketbeat Ratings reports. Several other brokerages have also recently issued reports on AMLX. Robert W. Baird assumed coverage on shares of Amylyx Pharmaceuticals in a report on Wednesday, January 3rd. They […]
Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 124,455 shares of the company’s stock, valued at approximately $2,279,000. Connor Clark […]
Connor Clark & Lunn Investment Management Ltd. bought a new stake in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Free Report) in the 3rd quarter, Holdings Channel.com reports. The fund bought 124,455 shares of the company’s stock, valued at approximately $2,279,000. Several other hedge funds and other institutional investors also recently made changes to their positions in […]
Primecap Management Co. CA purchased a new stake in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 304,900 shares of the company’s stock, valued at approximately $5,583,000. Primecap Management Co. CA owned […]